Walleye Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Walleye Capital's EW Position: Q3 2026 in Review
Walleye Capital increased its Edwards Lifesciences (EW) stake by 5,516% in Q3 2026, buying an estimated $2.04M and bringing the position to 23,362 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2813.
Walleye Capital first reported a position in EW in Q1 2019 and has held it in 15 quarters since. The position peaked at $23.3M in Q4 2025. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Walleye Capital held 23,362 shares of Edwards Lifesciences worth $2.02M as of Q3 2026.
- Walleye Capital bought 22,946 Edwards Lifesciences shares in Q3 2026, an estimated $2.04M.
- Edwards Lifesciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2813 holding.
- Walleye Capital first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 15 quarters since.
- Walleye Capital's Edwards Lifesciences position peaked at $23.3M in Q4 2025.
- 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.